Report Detail

Request for Sample of this report

Pharma & Healthcare Global Somatostatin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM2975180
    • |
  • 11 January, 2024
    • |
  • Global
    • |
  • 137 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Somatostatin market size was valued at USD 346.3 million in 2023 and is forecast to a readjusted size of USD 715 million by 2030 with a CAGR of 10.9% during review period.
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, followed by Europe and India.
The Global Info Research report includes an overview of the development of the Somatostatin industry chain, the market status of Hormonal Disorder (0.25mg/pcs, 0.75mg/pcs), Oncology (0.25mg/pcs, 0.75mg/pcs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Somatostatin.
Regionally, the report analyzes the Somatostatin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Somatostatin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Somatostatin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Somatostatin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., 0.25mg/pcs, 0.75mg/pcs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Somatostatin market.
Regional Analysis: The report involves examining the Somatostatin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Somatostatin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Somatostatin:
Company Analysis: Report covers individual Somatostatin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Somatostatin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hormonal Disorder, Oncology).
Technology Analysis: Report covers specific technologies relevant to Somatostatin. It assesses the current state, advancements, and potential future developments in Somatostatin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Somatostatin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Somatostatin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
0.25mg/pcs
0.75mg/pcs
3mg/pcs
Market segment by Application
Hormonal Disorder
Oncology
Metabolic Disorder
Others
Major players covered
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Somatostatin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Somatostatin, with price, sales, revenue and global market share of Somatostatin from 2019 to 2024.
Chapter 3, the Somatostatin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Somatostatin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Somatostatin.
Chapter 14 and 15, to describe Somatostatin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Somatostatin
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Somatostatin Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 0.25mg/pcs
    • 1.3.3 0.75mg/pcs
    • 1.3.4 3mg/pcs
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Somatostatin Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hormonal Disorder
    • 1.4.3 Oncology
    • 1.4.4 Metabolic Disorder
    • 1.4.5 Others
  • 1.5 Global Somatostatin Market Size & Forecast
    • 1.5.1 Global Somatostatin Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Somatostatin Sales Quantity (2019-2030)
    • 1.5.3 Global Somatostatin Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Merck (Schweiz) AG
    • 2.1.1 Merck (Schweiz) AG Details
    • 2.1.2 Merck (Schweiz) AG Major Business
    • 2.1.3 Merck (Schweiz) AG Somatostatin Product and Services
    • 2.1.4 Merck (Schweiz) AG Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Merck (Schweiz) AG Recent Developments/Updates
  • 2.2 SANOFI-AVENTIS FRANCE
    • 2.2.1 SANOFI-AVENTIS FRANCE Details
    • 2.2.2 SANOFI-AVENTIS FRANCE Major Business
    • 2.2.3 SANOFI-AVENTIS FRANCE Somatostatin Product and Services
    • 2.2.4 SANOFI-AVENTIS FRANCE Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 SANOFI-AVENTIS FRANCE Recent Developments/Updates
  • 2.3 Lyomark Pharma GmbH
    • 2.3.1 Lyomark Pharma GmbH Details
    • 2.3.2 Lyomark Pharma GmbH Major Business
    • 2.3.3 Lyomark Pharma GmbH Somatostatin Product and Services
    • 2.3.4 Lyomark Pharma GmbH Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Lyomark Pharma GmbH Recent Developments/Updates
  • 2.4 ALFA WASSERMANN S.p.A.
    • 2.4.1 ALFA WASSERMANN S.p.A. Details
    • 2.4.2 ALFA WASSERMANN S.p.A. Major Business
    • 2.4.3 ALFA WASSERMANN S.p.A. Somatostatin Product and Services
    • 2.4.4 ALFA WASSERMANN S.p.A. Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 ALFA WASSERMANN S.p.A. Recent Developments/Updates
  • 2.5 Polypeptide Laboratories, Inc
    • 2.5.1 Polypeptide Laboratories, Inc Details
    • 2.5.2 Polypeptide Laboratories, Inc Major Business
    • 2.5.3 Polypeptide Laboratories, Inc Somatostatin Product and Services
    • 2.5.4 Polypeptide Laboratories, Inc Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Polypeptide Laboratories, Inc Recent Developments/Updates
  • 2.6 SAMARTH
    • 2.6.1 SAMARTH Details
    • 2.6.2 SAMARTH Major Business
    • 2.6.3 SAMARTH Somatostatin Product and Services
    • 2.6.4 SAMARTH Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 SAMARTH Recent Developments/Updates
  • 2.7 UBPL
    • 2.7.1 UBPL Details
    • 2.7.2 UBPL Major Business
    • 2.7.3 UBPL Somatostatin Product and Services
    • 2.7.4 UBPL Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 UBPL Recent Developments/Updates
  • 2.8 HYBIO
    • 2.8.1 HYBIO Details
    • 2.8.2 HYBIO Major Business
    • 2.8.3 HYBIO Somatostatin Product and Services
    • 2.8.4 HYBIO Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 HYBIO Recent Developments/Updates
  • 2.9 TianTaiShan
    • 2.9.1 TianTaiShan Details
    • 2.9.2 TianTaiShan Major Business
    • 2.9.3 TianTaiShan Somatostatin Product and Services
    • 2.9.4 TianTaiShan Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 TianTaiShan Recent Developments/Updates
  • 2.10 Yangtze River
    • 2.10.1 Yangtze River Details
    • 2.10.2 Yangtze River Major Business
    • 2.10.3 Yangtze River Somatostatin Product and Services
    • 2.10.4 Yangtze River Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Yangtze River Recent Developments/Updates
  • 2.11 Siyao
    • 2.11.1 Siyao Details
    • 2.11.2 Siyao Major Business
    • 2.11.3 Siyao Somatostatin Product and Services
    • 2.11.4 Siyao Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Siyao Recent Developments/Updates
  • 2.12 Shuangcheng
    • 2.12.1 Shuangcheng Details
    • 2.12.2 Shuangcheng Major Business
    • 2.12.3 Shuangcheng Somatostatin Product and Services
    • 2.12.4 Shuangcheng Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Shuangcheng Recent Developments/Updates
  • 2.13 Hainan Zhonghe
    • 2.13.1 Hainan Zhonghe Details
    • 2.13.2 Hainan Zhonghe Major Business
    • 2.13.3 Hainan Zhonghe Somatostatin Product and Services
    • 2.13.4 Hainan Zhonghe Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Hainan Zhonghe Recent Developments/Updates
  • 2.14 SL PHARM
    • 2.14.1 SL PHARM Details
    • 2.14.2 SL PHARM Major Business
    • 2.14.3 SL PHARM Somatostatin Product and Services
    • 2.14.4 SL PHARM Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 SL PHARM Recent Developments/Updates
  • 2.15 Wuhan Hualong
    • 2.15.1 Wuhan Hualong Details
    • 2.15.2 Wuhan Hualong Major Business
    • 2.15.3 Wuhan Hualong Somatostatin Product and Services
    • 2.15.4 Wuhan Hualong Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Wuhan Hualong Recent Developments/Updates
  • 2.16 Qingdao Guoda
    • 2.16.1 Qingdao Guoda Details
    • 2.16.2 Qingdao Guoda Major Business
    • 2.16.3 Qingdao Guoda Somatostatin Product and Services
    • 2.16.4 Qingdao Guoda Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Qingdao Guoda Recent Developments/Updates
  • 2.17 Chengdu Shengnuo
    • 2.17.1 Chengdu Shengnuo Details
    • 2.17.2 Chengdu Shengnuo Major Business
    • 2.17.3 Chengdu Shengnuo Somatostatin Product and Services
    • 2.17.4 Chengdu Shengnuo Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Chengdu Shengnuo Recent Developments/Updates
  • 2.18 Longjin
    • 2.18.1 Longjin Details
    • 2.18.2 Longjin Major Business
    • 2.18.3 Longjin Somatostatin Product and Services
    • 2.18.4 Longjin Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Longjin Recent Developments/Updates

3 Competitive Environment: Somatostatin by Manufacturer

  • 3.1 Global Somatostatin Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Somatostatin Revenue by Manufacturer (2019-2024)
  • 3.3 Global Somatostatin Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Somatostatin by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Somatostatin Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Somatostatin Manufacturer Market Share in 2023
  • 3.5 Somatostatin Market: Overall Company Footprint Analysis
    • 3.5.1 Somatostatin Market: Region Footprint
    • 3.5.2 Somatostatin Market: Company Product Type Footprint
    • 3.5.3 Somatostatin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Somatostatin Market Size by Region
    • 4.1.1 Global Somatostatin Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Somatostatin Consumption Value by Region (2019-2030)
    • 4.1.3 Global Somatostatin Average Price by Region (2019-2030)
  • 4.2 North America Somatostatin Consumption Value (2019-2030)
  • 4.3 Europe Somatostatin Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Somatostatin Consumption Value (2019-2030)
  • 4.5 South America Somatostatin Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Somatostatin Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Somatostatin Sales Quantity by Type (2019-2030)
  • 5.2 Global Somatostatin Consumption Value by Type (2019-2030)
  • 5.3 Global Somatostatin Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Somatostatin Sales Quantity by Application (2019-2030)
  • 6.2 Global Somatostatin Consumption Value by Application (2019-2030)
  • 6.3 Global Somatostatin Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Somatostatin Sales Quantity by Type (2019-2030)
  • 7.2 North America Somatostatin Sales Quantity by Application (2019-2030)
  • 7.3 North America Somatostatin Market Size by Country
    • 7.3.1 North America Somatostatin Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Somatostatin Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Somatostatin Sales Quantity by Type (2019-2030)
  • 8.2 Europe Somatostatin Sales Quantity by Application (2019-2030)
  • 8.3 Europe Somatostatin Market Size by Country
    • 8.3.1 Europe Somatostatin Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Somatostatin Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Somatostatin Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Somatostatin Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Somatostatin Market Size by Region
    • 9.3.1 Asia-Pacific Somatostatin Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Somatostatin Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Somatostatin Sales Quantity by Type (2019-2030)
  • 10.2 South America Somatostatin Sales Quantity by Application (2019-2030)
  • 10.3 South America Somatostatin Market Size by Country
    • 10.3.1 South America Somatostatin Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Somatostatin Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Somatostatin Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Somatostatin Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Somatostatin Market Size by Country
    • 11.3.1 Middle East & Africa Somatostatin Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Somatostatin Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Somatostatin Market Drivers
  • 12.2 Somatostatin Market Restraints
  • 12.3 Somatostatin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Somatostatin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Somatostatin
  • 13.3 Somatostatin Production Process
  • 13.4 Somatostatin Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Somatostatin Typical Distributors
  • 14.3 Somatostatin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Somatostatin . Industry analysis & Market Report on Somatostatin is a syndicated market report, published as Global Somatostatin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Somatostatin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,784.00
    		4,176.00
    		5,568.00
    		3,250.32
    		4,875.48
    		6,500.64
    		547,508.40
    		821,262.60
    		1,095,016.80
    		290,197.20
    		435,295.80
    		580,394.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo